74.80 0.00 (0.00%)
After hours: 4:32PM EDT
Previous Close | 72.78 |
Open | 73.63 |
Bid | 74.79 x 800 |
Ask | 74.87 x 800 |
Day's Range | 73.01 - 76.91 |
52 Week Range | 31.86 - 100.77 |
Volume | 495,775 |
Avg. Volume | 689,131 |
Market Cap | 4.834B |
Beta (5Y Monthly) | 1.00 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -13.06 |
Earnings Date | May 05, 2021 - May 10, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 101.91 |
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), today announced that 22 abstracts, including three oral presentations, were accepted at the 2021 American Academy of Neurology (AAN) virtual annual meeting being held from April 17 – 22. The abstracts are available on the AAN website at https://index.mirasmart.com/AAN2021/.
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Biohaven Pharmaceutical's first-quarter pre-announcement for sales of migraine treatment Nurtec ODT crushed Wall Street's expectations Wednesday. BHVN stock surged on the news.